JMSCR Vol 05 Issue 08 Page August 2017

Similar documents
Helicobacter and gastritis

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans

Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings

Helicobacter pylori:an Emerging Pathogen

Disclosures. Co-founder and Chief Science Officer, TechLab

The Nobel Prize in Physiology or Medicine for 2005

594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications

Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia

Corporate Medical Policy

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.

- Helicobacter - THE EASE AND DIFFICULTY OF A NEW DISCOVERY. Robin Warren

RAPID DIAGNOSIS OF HELICOBACTER PYLORI INFECTION IN GASTRIC IMPRINT SMEARS

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

A COMPARATIVE STUDY BETWEEN IMMUNOHISTOCHEMISTRY, HEMATOXYLIN & EOSIN AND GEIMSA STAIN FOR HELICOBACTER PYLORI DETECTION IN CHRONIC GASTRITIS

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe

Table 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma

Helicobacter pylori Improved Detection of Helicobacter pylori

Framing Helicobacter pylori: The Etiology of Peptic Ulcers and Gastritis

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

Helicobacter Connections. Barry Marshall

The Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma

Gastric atrophy: use of OLGA staging system in practice

Gilles Jequier. Commercial Director Organobalance, a Novozymes Company

The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus

Index. Note: Page numbers of article titles are in boldface type.

Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of

Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study

Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology

H.pylori IgA Cat #

H.Pylori IgG

H.Pylori IgG Cat # 1503Z

Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology

MEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18

Imprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of Iran

Campylobacter. Helicobacter. Arcobacter 10/14/2011. General. Difference from Vibrio. Difference from Vibrio. Vibrio. Campylobacter

TRANSPARENCY COMMITTEE OPINION. 13 December 2006

H. pylori IgM CLIA kit

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z

H. pylori Antigen ELISA Kit

MOSAIC APPEARANCE OF GASTRIC MUCOSA AS A PREDICTOR FOR HELICOBACTER PYLORI INFECTION

New immunoassay for the detection of Helicobacter pylori infection compared with urease test,

(Received September 12, Accepted April 23, 1997) Jpn. J. Med. Sci. Biol., 50, 55-62, 1997.

Campylobacter like organisms on the gastric mucosa:

California Association for Medical Laboratory Technology

Clinical Policy: Helicobacter Pylori Serology Testing Reference Number: CP.MP.153

Histopathological study of gastric carcinoma with associated precursor lesions

THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN

PATHOGENESIS AND CURRENT TREATMENT OF H. PYLORI INFECTION. Jiannis Vlachogiannakos

Original Article. Abstract

H.Pylori IgM Cat # 1504Z

ORIGINAL ARTICLE ROLE OF H. PYLORI IN PATIENTS OF GASTRIC CANCER IN SOUTHERN ODISHA

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

Clinical Policy Title: Noninvasive testing for H. pylori

Update on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada

HELICOBACTER PYLORI UPDATE

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other

Comparative study of rapid urease test and histopathological examination for detection of H. pylori infection

Anti-CagA IgG Antibody Is Independent from Helicobacter pylori VacA and CagA Genotypes

What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?

Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT

Original Article. Is There Any Association between Helicobacter pylori CagA Status and Patient's Habits with Gastric Carcinoma

Clinical Policy Title: Breath Testing for H. Pylori

H. pylori Stool Rapid Test (Cassette)

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia

Research Article Reliability of Diagnostic Tests for Helicobacterpylori Infection

A histopathological study of association of Helicobacter pylori with gastric malignancies

Helicobacter pylori: drowning in a pool of blood?

Magaji et al., Afr. J. Infect. Dis. 2(2): THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD)

Peptic ulcer disease. Nomin-Erdene. D SOM-531

Prevalence of Helicobacter Pylori Infection Among Patients Undergoing Upper Gastrointestinal Endoscopy in a Medical College Hospital in Kerala, India

DIAGNOSIS AND TREATMENT OF HELICOBACTER PYLORI INFECTION IN VIETNAMESE CHILDREN

ISSN X (Print) Research Article

American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection

Rapid-VIDITEST. Helicobacter pylori. One step Helicobacter pylori Blister test. Instruction manual

Recent possibilities of detection of Helicobacter pylori. infection from biopsy tissue samples in chronic gastritis. diseases

Histopathological Characteristics of Atrophic Gastritis in Adult Population

Helicobacter pylori Infection in Children: A New Focus

SCIENTIFIC DISCUSSION

Bcl-2 Expression in CagA Strain H. Pylori Gastritis (Immunohistochemical and Insitu Hybridization Study)

ASSOCIATION OF HELICOBACTER PYLORI DENSITY WITH ENDOSCOPIC AND HISTOPATHOLOGICAL FINDINGS

HELICOBACTER PYLORI ERADICATION TREATMENT AND THE RISK OF GASTRIC AND OESOPHAGEAL CANCER

Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens

Key words : low-grade MALT lymphoma, epithelial change, empty lamina propria, B-cell clonality, H. pylori, eradication, long-term follow-up

Sequioa Education Systems, Inc. 1

Histopathological study of Helicobacter Pylori bearing Gastric Biopsies for Gastric Lesions

Journal of Medical Science & Technology

Detection of H. Pylori by Different Conventional Staining Methods and Immunohistochemistry in Sudanese Patients with Chronic Gastritis

Study of Incidence of Helicobacter Organisms in Cases of Gastritis.

Transcription:

www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i8.83 Role of Special Stain Giemsa in Demonstration of Helicobacter Pylori in Gastric Biopsies Authors Dr Ruby Elizabeth Elias 1, Dr Bindiya Gisuthan 2, Dr Deepthi Raj M.L 3 1 Assistant Professor, Department of Pathology, Government Medical College, Thiruvananthapuram, Kerala 2 Assistant Professor, Dept of Pathology, Government Medical College, Thiruvananthapuram, Kerala, India 3 Assistant Professor, Dept of Pathology, Government Medical College, Thiruvananthapuram, Kerala, India, Corresponding Author Dr Bindiya Gisuthan Assistant Professor, Department of Pathology, Government Medical College, Thiruvananthapuram, Kerala, India Pin-695011 Phone no: 9447250510, 0471-2444283, Email: bindiyarakesh@gmail.com ABSTRACT Introduction: Helicobacter pylori is a gram negative, curved bacillus, found in the gastric mucosa which was recognized as a Class I carcinogen. Majority of gastric adenocarcinomas and most gastric MALT lymphomas are related to chronic infection with this organism. Various invasive and noninvasive methods are available for the identification of H.pylori. The gold standard for the diagnosis remains to be histopathology and culture. But culture is a laborious and time consuming method. Histopathological identification of H.pylori can be improved with the use of special stains like Giemsa. The aim of this study was to evaluate the efficacy of the special stain (Giemsa) in the identification of H.pylori compared to the routine H &E stain (Hematoxylin and Eosin). Materials and Methods: Gastric biopsies taken from dyspeptic patients were evaluated with routine H&E and Giemsa stains. The presence of H.pylori was analysed in both the groups. Results: Out of 150 cases studied Giemsa stain revealed H.pylori in 58.67% of cases whereas routine H & E stain identified only 44.67% of cases. This was found to be statistically significant. Discussion and Conclusion: Special stain like Giemsa should definitely be used as an adjunct to standard H &E stain for the identification of H.pylori in gastric biopsies. The depiction of H.pylori in gastric biopsies allows for the specific treatment by which the eradication of the organism can be done, thereby decreasing the incidence of gastric carcinoma and MALT Lymphoma. Keywords: Giemsa, Gastritis, Hematoxylin and Eosin stain. INTRODUCTION Helicobacter pylori is a Gram negative, microaerophilic, spiral shaped bacterium, measuring 0.5-1.0µm 2.5-5.0µm in size. It is motile, has 4-6 sheathed flagella, attached at one pole. The organismcan live in the acidic environment of the stomach by its special structure and virulence factors like vacuolatingcytotoxin (VacA), which causes cytoplasmic vacuolization in gastric epithelial cells and cytotoxin associated antigen (CagA). It has the ability to produce various enzymes like Dr Ruby Elizabeth Elias et al JMSCR Volume 05 Issue 08 August 2017 Page 26482

hydrogenase, urease, oxidase and catalase, which also contributes to its existence in gastric mucosa. This organism was first discovered by Dr. Barry Marshall and Robin Warren in the gastric mucosa of patients with gastritis and ulcers in 1982. 1 In 1875 itself, German scientists found spiral-shaped bacteria in the lining of the human stomach, but they were unable to culture them. It was called Campylobacter pyloridis initially, then renamed C.pylori. Later in 1989, following the genetic studies it was named Helicobacter pylori. The prevalence of H. pylori in the India is as high as 80percent. 2 The common diseases caused by H.pylori are chronic active gastritis and gastric and duodenal peptic ulcers, In a subset of patients, active gastritis can evolve in to chronic gastritis,atrophic gastritis, intestinal metaplasia and precancerous states like dysplasia and finally to carcinoma over the course of many years. In India the most common manifestation of H. pylori infection is peptic ulcer disease, especially duodenal ulcer disease. 3 H. pylori was considered as a Class I (Definite)carcinogen by International Agency for Research on Cancer (IARC), a subordinate organization of WHO in 1994, based on epidemicological data.70% of gastric adenocarcinomas and most gastric MALT lymphomas are related to chronic infection with this organism. Various methods are available for the identification of H.pylori in gastric biopsies. This includes non-invasive and invasive techniques. Noninvasive methods include urea breath test(ubt), Stool antigen test and serology(anti- H. pylori IgG antibody). Invasive techniques include Rapid Urease Test, histopathology, culture and Polymerase Chain Reaction (PCR).Many studies were done around the world comparing the different methods with varying outcome.among these, the gold standard for the diagnosis remains to be culture and histology. But culture is a laborious and time consuming method. Histology is highly sensitive and specific especially in combination with special stains. When compared to other methods, histology has the added advantage of directly visualizing the bacteria and surrounding mucosal changes can be found out ranging from inflammation to malignancy. Almost 100% diagnostic accuracy is reported when histology along with Immunohistochemistry is done, but the test is costly. In a developing country like India where health fund allocation is minimal, a cost effective, yet highly sensitive and specific test need to be identified. Of all the special stains described in histology, Giemsa is simple, cheaper and give consistently good results for H. pylori. 4 This study was undertaken to compare the efficacy of the special stain Giemsa with the routine H&E staining for better identification of H.pylori. MATERIALS & METHODS 150 consecutive biopsies from patients presented with dyspeptic symptoms like postprandial fullness, early satiation, and epigastric pain or burning were evaluated. Endoscopy was done and biopsies taken from antrum and or body were included in the study. Clinical details & other relevant information were obtained from the hospital records. Patients with gastrointestinal malignancy and gastrectomy specimens were excluded from the study. All specimens were Formalin fixed & Paraffin embedded. Minimum 2 sections were taken from each biopsy specimen and were stained with H&E and Giemsa. For preparing stock solution of Giemsa,4 gram of stain powder was dissolved in 250 ml glycerol at 60 C with regular shaking. 250 ml of methanol was added, shaken the mixture and allowed to stand for 7 days. Working Giemsa stain was prepared by adding 4ml of Giemsa stock solution to 96 ml of Acetate buffered distilled water,(ph 6.8). All cases were evaluated microscopically under oil immersion objective(1000 X)for the presence of H.pylori. Organisms showing typical morphology were selected. Doubtful isolated forms were excluded. The problematic cases were reevaluated by a second pathologist. All the data obtained were entered in a master sheet in Microsoft Excel. The results were compared and Dr Ruby Elizabeth Elias et al JMSCR Volume 05 Issue 08 August 2017 Page 26483

p value less than 0.05 was considered significant. Sensitivity, Specificity, Positive and Negative Predictive Values were calculated. RESULTS Total of 150 cases were evaluated. Age of the patients ranged from 7 to 82 years. Majority of the H pylori positive cases were in the age group of 51-60 years (20.45%).Table 1 Males were more affected than females. Male to female ratio was 3:2.Table 2 In H& E stained sections, curvilinear, eosinophilic organism was seen in the mucous layer of gastric lining epithelium. Figure 3.In Giemsa stained sections, the organism had blue colour in a pale blue back ground. Figure 4. Out of 150 cases, H&E staining detected 67 cases (44.67%) of H.pylori. In 83 sections stained with H&E the organism was not identified. With Giemsa stain, 88 cases (58.67%) showed positivity for H.pylori while 62 cases were negative. In 1 case (0.67%), H.pylori was identified in H&E stain,but not visible with Giemsastain. The proportion of cases showing positivity with Giemsa stain was found to be significant, pvalue being 0.015. using N-1 Chisquared test. Table 5 The sensitivity, specificity, positive predictive value and negative predictive value of H&E stain in comparison with Giemsa stain were also calculated. Sensitivity was found to be 75.86%, Specificity was 98.41%,Positive Predictive Value was 98.51% and Negative Predictive Value was 74.70%. Table 6 Table 1- Age distribution of patients showing H. pylori positivity Age group Total number of biopsies Number of cases showing positivity for H.pylori 0-10 3 1 11-20 12 8 21-30 21 15 31-40 27 17 41-50 24 16 51-60 32 18 61-70 18 8 71-80 12 5 81-90 1 0 Table 2-Sex distribution of patients showing H. pylori positivity Figure 3-H. pylori : H& E stain Figure 4-H.Pylori:Giemsa stain Dr Ruby Elizabeth Elias et al JMSCR Volume 05 Issue 08 August 2017 Page 26484

Table 5- Number of cases showing positivity with H & E stain and Giemsa stain Identification Of H.pylori H&E stain Giemsa stain Positive 67 44.67% 88 58.67% Negative 83 55.33% 62 41.33% Total 150 150 Table 6-Sensitivity, Specificity,PPV and NPV of H &E stain Sensitivity 75.86%, Specificity 98.41%, PPV 98.51% NPV 74.70%. DISCUSSION The availability of an array of diagnostic methods for the identification of H.pylori denotes the incompetency of any one test to pinpoint the diagnosis. Non-invasive diagnostic tests included urea breath test, stool antigen test and serology. Invasive tests include endoscopy, histology, rapid urease test, culture, and molecular methods. Non Invasive diagnostic tests Urea breath test (UBT) is the most popular, accurate and reproducible noninvasive test useful for the diagnosis of H. pylori infection. The ingested 13C- or 14C-labeled urea is hydrolyzed to CO2 in stomach by the urease activity of H. pylori, then this labeled CO2 exhaled is measured. It has 95% sensitivity and specificity. Stool Antigen Test(SAT) It has got good sensitivity (95%) and specificity(98%).the test is based on enzyme immunoassay (EIA) orimmune chromatography assay (ICA) to detect H. pylori antigens in stool samples.no significant reduction in the sensitivity after treatment with Proton Pump Inhibitors. 5 Serological tests based on the detection of anti- H.pyloriIg G antibody are available for H. pylori detection. Enzyme inked Immunosobent Assay is the most common and accurate technique. It is also used in screening for epidemiological studies. Ulcer bleeding, gastric atrophy or the intake of PPI or antibiotics will not affect the test result. The problem with serological test is that it do not differentiate between active infection and past exposure to H. pylori because even after successful eradication antibody levels remain in the blood for longer time. Sensitivity and specificity varies depending on the type of serological test performed. Invasive diagnostic tests RUT (Rapid Urease Test) is highly specific (95-100%),economical, simple and rapid method.more than 10,000 bacteria are required for a positive diagnosis. Drug intake can result in falsenegative results. Other urease producing bacteria in the stomach causes false positive. 6 Culture is the highly specific method for detection of H. pylori infection, but the sensitivity varies widely depending on the quality and transport of specimens, exposure to aerobic environment,technical errors etc. 7 It is also used in population with high antibacterial resistance. PCR is now used for the diagnosis of H. pylorinot only from gastric biopsy specimens, also from saliva, gastric juice, stool etc. It has higher sensitivity (95%)and specificity compared to other conventional tests. Advantages of PCR include, positive result even if fewer bacteria are present in the sample, faster results and no need for special processing or transportation. Test material for RT- PCR can be taken from tissue in paraffin blocks. Also, PCR detects specific mutations and virulence factors, such as CagA and VacA. This helps to understand the variation in clinical presentation with different strains of H. pylori. Many studies demonstrated that the presence of virulence factors, such as CagA and VacA gene, are associated with severe inflammation of the gastric mucosa and higher prevalence of peptic ulcer disease and gastric cancer. PCR also detect H. pylori in environmental samples for epidemiological studies. But some studies showed that blind rely on PCR data alone for treatment decisions on H. pylori is not advisable. Antigenic cross-reactivity can give rise to false positivity.8 Histology is considered to be the gold standard for direct demonstration of H. pylori infection and is also the first method used for the detection of H. pylori. But, the accurate diagnosis is influenced by Dr Ruby Elizabeth Elias et al JMSCR Volume 05 Issue 08 August 2017 Page 26485

various factors like site, size and number of biopsies, staining methods, intake of proton pump inhibitor (PPI) and antibiotics and expertise of the pathologist. The updated Sydney system recommend to take five biopsy specimens from different sites. If a single biopsy is taken, the gastric body greater curvature is the preferred site. Several stains were described for the better identification of the organism other than the routine H&E stain including Warthin- starry stain used originally by Marshall and Warren, Genta, silver stain, toluidine blue, acridine orange, McMullen, Dieterle and immunohistochemical stains. Warthin-Starry stain is expensive and the results not always reliable. Genta stain is a combination of silver, H&E, and Alcian blue stains which identifies the inflammatory cells and H. pylori. But it is time-consuming, complex and expensive method. 9 The significance of using ancillary techniques is more important nowadays due to the widespread use of proton pump inhibitors, which can cause reduction in the number and change in the morphology of H pylori,the organism colonizing proximal stomach, that too in deeper layers. Ancillary techniques especially Immunohistochemistry showed near 100% sensitivity and specificity in many studies. But cost effectiveness of it is still under debate, especially in developing countries. So it s use is usually limited to those biopsy specimens which show moderate and severe chronic gastritis, but no H. pylori identified in H&E and special staining. In this study, 44.67% of gastric biopsies revealed the presence of H pylori by H&E stain, while Giemsa stain showed 58.67% positivity. This result is comparable to findings in other studies which showed positivity of 54.5% by the routine H&E stain and 68.7% by Giemsa stain. 10 When comparing the proportion of cases showing the organism by the two methods, p value was found to be significant (p value= 0.015). According to many studies, Giemsa stain is the method of choice when comparing different special stains because it is sensitive, cheap, easy to perform, and reproducible. 11 The prevalence of H pylori in gastric biopsy is 58.7 % similar to other studies in South India, showing 59.4 % prevalence. 12 According to this study, the sensitivity and specificity of H&E stain were 75.86%, and 98.41%, respectively. This is in concordance with similar studies showing sensitivity of 70% - 98 % and specificity of 90-98% with H&E stain.however in cases showing low density of organisms, the specificity of H&E was low compared to Giemsa. 13 Hartman and Owens review showed 83.3% sensitivity of H&E-stained sections. 11 Compared to that review, the sensitivity of H&E in this study was less, may be because organisms with typical morphology only were included in this study. Regarding limitation of this study, even though histopathology shows high diagnostic sensitivity and specificity for H pylori detection, various factors like biopsy sites and numbers, staining methods and intake of drugs like PPI can influence the results. Turnaround time for histological diagnosis was another drawback compared to noninvasive methods. Also IHC could have been done to increase the diagnostic accuracy. CONCLUSION Although several noninvasive and invasive methods are available for the detection of H pylori, histopathological evaluation of endoscopic biopsy still plays a prominent role in the diagnostic scenario. According to this study, the diagnostic yield of histology is improved with the help of special stain Giemsa which is cost effective, simple and give consistent results. It is a good practice to do Giemsa stain along with H&E stain for H pylori demonstration in routine gastric biopsies. Source of support(grants)-none REFERENCES 1. MarshallBJ,WarrenJR.Unidentified curved bacilli in the stomach of patients with Dr Ruby Elizabeth Elias et al JMSCR Volume 05 Issue 08 August 2017 Page 26486

gastritis and peptic ulceration.lancet.1984 Jun 16;1(8390):1311-5 2. Selvi Thirumurthi,David Y. Graham. Helicobacter pylori infection in India from a western perspective. Indian J Med Res. 2012 Oct; 136(4): 549 562 3. Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. J GastroenterolHepatol. 2002;17:659 65 4. Cha MS. Comparative analysis of histochemical stains about detection of H. pylori in gastric mucosa. Korean J Clin Lab Sci 2007;39:223-30. 5. Kodama M, Murakami K, Okimoto T, Fukuda Y, Shimoyama T, Okuda M, Kato C, Kobayashi I, Fujioka T. Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test.world J Gastroenterol. 2012 Jan 7;18(1):44-48 6. Tseng CA, Wang WM, Wu DC. Comparison of the clinical feasibility of three rapid urease tests in the diagnosis of Helicobacter pylori infection. Dig Dis Sci 2005;50:449-52. 7. Hirschl AM, Makristathis A. Methods to detect Helicobacter pylori: from culture to molecular biology. Helicobacter 2007;12:6-11. 8. Mitsushige Sugimoto, Jeng-Yih Wu, Suhaib Abudayyeh, Jill Hoffman, Hajer Brahem, Khaldun Al-Khatib, Yoshio Yamaoka, David Y. Graham. Unreliability of Results of PCR Detection of Helicobacter pylori in Clinical or Environmental Samples J. Clin. Microbiol. March 2009;47(3): 738-40 9. Ramis IB, de Moraes EP, Fernandes MS, et al. Evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens of dyspeptic patients. Braz J Microbiol 2012;43:903-8. 10. Marcela S. Boldt, Rivelle D. Pereira, Alfredo J. A,Barbosa. Histological identification of H. pylori stained by hematoxylin-eosin and Giemsa:review for quality control. J Bras Patol Med Lab.2015April ;51( 2) :108-112 11. Hartman DJ, Owens SR. Are routine ancillary stains required to diagnose Helicobacter infection in gastric biopsy specimens? An institutional quality assurance review. American journal of clinical pathology. 2012Feb; 137(2): 255-60. 12. S Adlekha, T Chadha, P Krishnan, B Sumangala.Prevalence of Helicobacter Pylori Infection Among Patients Undergoing Upper Gastrointestinal Endoscopy in a Medical College Hospital in Kerala, India.Ann Med Health Sci Res. 2013 Oct-Dec; 3(4): 559 563 13. Laine L, Lewin DN, Naritoku W, et al. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. GastrointestEndosc 1997;45:463-7. Dr Ruby Elizabeth Elias et al JMSCR Volume 05 Issue 08 August 2017 Page 26487